Evaxion Biotech A/S (EVAX) Competitors $0.93 -0.03 (-3.21%) (As of 03:57 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends EVAX vs. SNTI, INKT, CLDI, ATHA, INAB, CGTX, FNCH, CYTH, NKGN, and AIMShould you be buying Evaxion Biotech A/S stock or one of its competitors? The main competitors of Evaxion Biotech A/S include Senti Biosciences (SNTI), MiNK Therapeutics (INKT), Calidi Biotherapeutics (CLDI), Athira Pharma (ATHA), IN8bio (INAB), Cognition Therapeutics (CGTX), Finch Therapeutics Group (FNCH), Cyclo Therapeutics (CYTH), NKGen Biotech (NKGN), and AIM ImmunoTech (AIM). These companies are all part of the "biological products, except diagnostic" industry. Evaxion Biotech A/S vs. Senti Biosciences MiNK Therapeutics Calidi Biotherapeutics Athira Pharma IN8bio Cognition Therapeutics Finch Therapeutics Group Cyclo Therapeutics NKGen Biotech AIM ImmunoTech Senti Biosciences (NASDAQ:SNTI) and Evaxion Biotech A/S (NASDAQ:EVAX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking. Does the MarketBeat Community believe in SNTI or EVAX? Evaxion Biotech A/S received 19 more outperform votes than Senti Biosciences when rated by MarketBeat users. Likewise, 63.89% of users gave Evaxion Biotech A/S an outperform vote while only 40.00% of users gave Senti Biosciences an outperform vote. CompanyUnderperformOutperformSenti BiosciencesOutperform Votes440.00% Underperform Votes660.00% Evaxion Biotech A/SOutperform Votes2363.89% Underperform Votes1336.11% Do analysts recommend SNTI or EVAX? Senti Biosciences presently has a consensus target price of $10.00, suggesting a potential upside of 94.17%. Evaxion Biotech A/S has a consensus target price of $11.00, suggesting a potential upside of 1,050.27%. Given Evaxion Biotech A/S's higher probable upside, analysts clearly believe Evaxion Biotech A/S is more favorable than Senti Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Senti Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Evaxion Biotech A/S 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is SNTI or EVAX more profitable? Senti Biosciences has a net margin of 0.00% compared to Evaxion Biotech A/S's net margin of -347.83%. Evaxion Biotech A/S's return on equity of 0.00% beat Senti Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Senti BiosciencesN/A -154.84% -77.42% Evaxion Biotech A/S -347.83%N/A -79.40% Does the media favor SNTI or EVAX? In the previous week, Evaxion Biotech A/S had 4 more articles in the media than Senti Biosciences. MarketBeat recorded 6 mentions for Evaxion Biotech A/S and 2 mentions for Senti Biosciences. Senti Biosciences' average media sentiment score of -0.02 beat Evaxion Biotech A/S's score of -0.33 indicating that Senti Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Senti Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evaxion Biotech A/S 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 3 Very Negative mention(s) Neutral Which has preferable earnings & valuation, SNTI or EVAX? Evaxion Biotech A/S has higher revenue and earnings than Senti Biosciences. Evaxion Biotech A/S is trading at a lower price-to-earnings ratio than Senti Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSenti Biosciences$2.56M9.23-$71.06M-$15.56-0.33Evaxion Biotech A/S$3.30M1.70-$22.12M-$0.29-3.30 Which has more risk & volatility, SNTI or EVAX? Senti Biosciences has a beta of 2.69, suggesting that its share price is 169% more volatile than the S&P 500. Comparatively, Evaxion Biotech A/S has a beta of -0.39, suggesting that its share price is 139% less volatile than the S&P 500. Do insiders and institutionals hold more shares of SNTI or EVAX? 25.7% of Senti Biosciences shares are owned by institutional investors. Comparatively, 11.0% of Evaxion Biotech A/S shares are owned by institutional investors. 15.9% of Senti Biosciences shares are owned by insiders. Comparatively, 41.6% of Evaxion Biotech A/S shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryEvaxion Biotech A/S beats Senti Biosciences on 10 of the 17 factors compared between the two stocks. Ad Diversified Trading InstituteGenesis leading the smart algo revolution?I’m revealing an exciting breakthrough that can help trade the markets unlike anything you’ve ever seen before… Because with my BRAND NEW smart algo you’ll always have a constant stream of alerts firing off in your back pocket to choose from. Here’s why: It does all the heavy lifting for you… automatically. Stock Ticker, Entry Price, Profit Target, Stop Loss, and even an Individual Chart!You’ll want to see what I’ve put on this page right here Get Evaxion Biotech A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for EVAX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVAX vs. The Competition Export to ExcelMetricEvaxion Biotech A/SBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.16M$2.98B$5.14B$9.31BDividend YieldN/A1.85%4.81%4.06%P/E Ratio-3.3047.03135.3117.54Price / Sales1.70420.231,215.74139.37Price / CashN/A182.1340.5837.95Price / Book-0.823.924.884.92Net Income-$22.12M-$42.03M$118.89M$225.78M7 Day Performance-26.44%-3.37%16.99%-1.58%1 Month Performance-43.75%7.95%16.58%6.67%1 Year Performance-85.49%21.00%35.26%22.48% Evaxion Biotech A/S Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVAXEvaxion Biotech A/S2.9295 of 5 stars$0.93-3.2%$11.00+1,088.4%-85.5%$5.43M$3.30M-3.1949Short Interest ↓SNTISenti Biosciences2.799 of 5 stars$5.15-7.5%$10.00+94.2%+34.8%$23.63M$2.56M-0.334News CoverageGap DownINKTMiNK Therapeutics3.0524 of 5 stars$0.59-5.0%$6.50+1,011.1%-47.2%$23.14MN/A-1.4930News CoveragePositive NewsCLDICalidi Biotherapeutics1.806 of 5 stars$1.74-6.2%$16.67+860.6%N/A$22.69M$50,000.000.0041ATHAAthira Pharma2.9313 of 5 stars$0.58-0.5%$13.83+2,276.5%-74.6%$22.51MN/A-0.2140News CoveragePositive NewsINABIN8bio3.5565 of 5 stars$0.28-0.3%$7.75+2,628.9%-84.9%$20.59MN/A-0.3820Gap UpCGTXCognition Therapeutics2.6409 of 5 stars$0.46-4.5%$8.00+1,652.8%-77.7%$18.96MN/A-0.4920Gap UpTrading HaltedFNCHFinch Therapeutics GroupN/A$11.75-2.1%N/A+228.5%$18.87M$110,000.00-1.36190Gap DownCYTHCyclo Therapeutics3.3215 of 5 stars$0.57-1.7%$0.95+66.7%-51.8%$16.40M$870,725.00-0.649Gap DownNKGNNKGen BiotechN/A$0.46-7.8%N/A-86.5%$16.30M$80,000.00-0.09N/AAIMAIM ImmunoTech2.0922 of 5 stars$0.22+0.2%$2.75+1,153.4%-55.5%$13.99M$190,000.00-0.4720News CoverageGap Down Related Companies and Tools Related Companies Senti Biosciences Competitors MiNK Therapeutics Competitors Calidi Biotherapeutics Competitors Athira Pharma Competitors IN8bio Competitors Cognition Therapeutics Competitors Finch Therapeutics Group Competitors Cyclo Therapeutics Competitors NKGen Biotech Competitors AIM ImmunoTech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EVAX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evaxion Biotech A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Evaxion Biotech A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
